There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved ...

A bold funding initiative aims to help scientists predict a T cell’s target antigens, with implications far beyond cancer ...

According to a recent study, researchers are developing nanotechnology that can improve the treatment of one of the most ...

T cell engagers are an exciting area of immunotherapy that remains in the early innings of development. We believe gamma-delta T cells offer unique properties, including tissue residence, phagocytosis ...

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine ...

The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new ...

Parker Institute for Cancer Immunotherapy has named Karen E. Knudsen, MBA, PhD, as its new CEO, according to a press ...

Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal ...

Immunotherapy is a type of cancer treatment that helps your immune system detect and fight cancer cells. Treatments may be administered via a catheter, intravenously, or by injection. There are ...

The doctor said that with her diagnosis, patients have six to nine months left to live. However, on Friday, Dukhi exceeded ...